Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats.
Status epilepticus in a child secondary to ingestion of skin-lightening cream.
Probing adenylation: using a fluorescently labelled ATP probe to directly label and immunoprecipitate VopS substrates.
Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder.
See All 9 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder.
Appelbaum KL. Stimulant use under a prison treatment protocol for attention-deficit/hyperactivity disorder. J Correct Health Care. 2011 Jul; 17(3):218-25.
View in:
PubMed
subject areas
Attention Deficit Disorder with Hyperactivity
Central Nervous System Stimulants
Humans
Male
Prevalence
Prisons
authors with profiles
Kenneth L Appelbaum MD